The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Nemkova S.A.
Pirogov Russian National Research Medical University, Moscow, Russia
Semenov D.V.
Russian State Social Unoversity, Moscow, Russia
Petrova E.A.
FGBU "NII onkologii im. N.N. Petrova" Minzdrava Rossii, Sankt-Peterburg
Savchenko D.V.
Russian State Social Unoversity, Moscow, Russia
Zavadenko N.N.
Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakulteta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva
Vozvyshaeva M.Yu.
Pirogov Russian National Research Medical University, Moscow, Russia
Kanishcheva A.S.
Russian State Social Unoversity, Moscow, Russia
Ralleva A.V.
Russian State Social Unoversity, Moscow, Russia
Logvinova E.M.
Russian State Social Unoversity, Moscow, Russia
Tsvetkov D.A.
Russian State Social Unoversity, Moscow, Russia
Charikova E.V.
Russian State Social Unoversity, Moscow, Russia
Romanenko N.I.
Russian State Social Unoversity, Moscow, Russia
Zagaryan D.A.
Russian State Social Unoversity, Moscow, Russia
Boldyrev V.G.
Pirogov Russian National Research Medical University, Moscow, Russia
Cognitive and emotional disorders in university students and teachers: the possibility of treatment with recognan (citicoline)
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12): 11‑18
Read: 3091 times
To cite this article:
Nemkova SA, Semenov DV, Petrova EA, et al. . Cognitive and emotional disorders in university students and teachers: the possibility of treatment with recognan (citicoline). S.S. Korsakov Journal of Neurology and Psychiatry.
2018;118(12):11‑18. (In Russ.)
https://doi.org/10.17116/jnevro201811812111
Objective. To study the efficacy of recognan (citicoline) in treatment of cognitive, emotional, autonomic, asthenic disorders in university students and teachers. Material and methods. Fifty-eight subjects (17 men and 41 women), mean age 27.75±12.05 years, including who 42 students and 16 teachers were studied. The sample was randomized into 2 groups (29 each): the main sub-group received oral therapy with recognan for 30 days, while the daily dosage was 500 mg (5 ml). In the control group, no drug therapy was performed. Patient’s state was assessed with a large battery of psychological tests and psychometric scales. The follow-up period was 30 days. All participants were examined three times (initially, in the middle of the study (day 15), in the end of the study (day 30)). Results and conclusion. Asthenic state was detected in 69%, autonomic dysfunction in 82.7%, sleep disorders in 75.8% of subjects. A high level of state anxiety was revealed in 22.2%, trait anxiety in 29.8%, a high level of stress was determined in 6,9%. It is shown that the use of recognan (citicoline) has a positive effect on compensation of autonomic and asthenic disorders, improves cognitive status, corrects psycho-emotional disorders, when used as a short (2 week) and month course.
Keywords:
Authors:
Nemkova S.A.
Pirogov Russian National Research Medical University, Moscow, Russia
Semenov D.V.
Russian State Social Unoversity, Moscow, Russia
Petrova E.A.
FGBU "NII onkologii im. N.N. Petrova" Minzdrava Rossii, Sankt-Peterburg
Savchenko D.V.
Russian State Social Unoversity, Moscow, Russia
Zavadenko N.N.
Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakulteta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva
Vozvyshaeva M.Yu.
Pirogov Russian National Research Medical University, Moscow, Russia
Kanishcheva A.S.
Russian State Social Unoversity, Moscow, Russia
Ralleva A.V.
Russian State Social Unoversity, Moscow, Russia
Logvinova E.M.
Russian State Social Unoversity, Moscow, Russia
Tsvetkov D.A.
Russian State Social Unoversity, Moscow, Russia
Charikova E.V.
Russian State Social Unoversity, Moscow, Russia
Romanenko N.I.
Russian State Social Unoversity, Moscow, Russia
Zagaryan D.A.
Russian State Social Unoversity, Moscow, Russia
Boldyrev V.G.
Pirogov Russian National Research Medical University, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.